PTN Palatin Technologies, Inc. Stock Quote

PTN [AMEX]

Index	-	P/E	-	EPS (ttm)	-0.09	Insider Own	6.20%	Shs Outstand	236.35M	Perf Week	35.39%
Market Cap	261.93M	Forward P/E	-	EPS next Y	-0.04	Insider Trans	0.00%	Shs Float	221.15M	Perf Month	87.61%
Income	-21.90M	PEG	-	EPS next Q	-0.02	Inst Own	15.20%	Short Float	3.46%	Perf Quarter	163.03%
Sales	-0.27M	P/S	-	EPS this Y	-158.00%	Inst Trans	0.07%	Short Ratio	1.57	Perf Half Y	89.29%
Book/sh	0.33	P/B	3.21	EPS next Y	50.00%	ROA	-23.70%	Target Price	-	Perf Year	51.84%
Cash/sh	0.35	P/C	3.02	EPS next 5Y	-	ROE	-26.10%	52W Range	0.35 - 1.25	Perf YTD	56.85%
Dividend	-	P/FCF	-	EPS past 5Y	8.10%	ROI	-29.40%	52W High	-15.20%	Beta	1.68
Dividend %	-	Quick Ratio	7.40	Sales past 5Y	-60.90%	Gross Margin	-	52W Low	198.59%	ATR	0.10
Employees	20	Current Ratio	7.90	Sales Q/Q	-	Oper. Margin	-	RSI (14)	72.99	Volatility	14.85% 12.85%
Optionable	No	Debt/Eq	0.00	EPS Q/Q	13.70%	Profit Margin	-	Rel Volume	1.67	Prev Close	1.06
Shortable	Yes	LT Debt/Eq	0.00	Earnings	Nov 17 BMO	Payout	-	Avg Volume	4.85M	Price	1.06
Recom	1.30	SMA20	32.26%	SMA50	80.21%	SMA200	101.97%	Volume	0	Change	0.00%

Jun-05-15

Reiterated

Canaccord Genuity

Buy

$4 → $6

Jan-12-15

Reiterated

ROTH Capital

Buy

$6 → $4

May-23-12

Initiated

Noble Financial

Buy

Jan-23-07

Initiated

Next Generation

Buy

Dec-22-20 01:17PM	These 2 Penny Stocks Are Poised for a Massive Rally, Say Analysts TipRanks +32.63%
Dec-15-20 07:00AM	Palatin Technologies Announces Positive Results From its Phase 2 Study of PL9643 in Patients With Dry Eye Disease PR Newswire -6.70%
Nov-29-20 12:13PM	Here is What Hedge Funds Think About Palatin Technologies, Inc. (PTN) Insider Monkey
Nov-19-20 11:11AM	Palatin Technologies (PTN) Surges: Stock Moves 8% Higher Zacks
Nov-17-20 09:15AM	Palatin Technologies, Inc. to Host Earnings Call ACCESSWIRE
07:30AM	Palatin Technologies, Inc. Reports First Quarter Fiscal Year 2021 Results and Provides Business Update PR Newswire
Nov-12-20 07:30AM	Palatin Technologies, Inc. to Report First Quarter, Fiscal Year 2021 Results; Teleconference and Webcast to be held on November 17, 2020 PR Newswire
Sep-28-20 09:00AM	Palatin Technologies, Inc. to Host Earnings Call ACCESSWIRE
07:30AM	Palatin Technologies, Inc. Announces Fourth Quarter and Fiscal Year 2020 Financial Results and Provides a Business Update PR Newswire
Sep-24-20 04:00PM	Palatin Technologies, Inc. to Report Fourth Quarter and Fiscal Year End 2020 Results; Teleconference and Webcast to be held on September 28, 2020 PR Newswire
Sep-10-20 05:47PM	Palatin Technologies To Present At The H.C. Wainwright & Co. 22nd Annual Global Investment Conference PR Newswire
Aug-13-20 04:12PM	Palatin Technologies Participates In Canaccord Genuity's 40th Annual Growth Conference PR Newswire
Jul-14-20 01:19PM	5 Health Care Stocks Trading With Low Price-Earnings Ratios GuruFocus.com
Jul-08-20 07:30AM	Palatin Technologies, Inc. Announces Reinitiation of Enrollment of Phase 2 Study with PL9643 for the Treatment of Dry Eye Disease PR Newswire
Jun-29-20 07:30AM	Palatin Technologies Announces Adjournment of Annual Meeting of Stockholders PR Newswire
Jun-23-20 04:54PM	Dow, S&P extend gains to second straight session, Nasdaq books fresh record close as Apple powers to new high MarketWatch +23.45%
02:38PM	Coronavirus update: U.S. case tally surging with more than half the states trending up as death toll tops 120,000 MarketWatch
08:05AM	Palatin's stock rises on plans to test experimental drug as COVID-19 treatment MarketWatch
07:30AM	Palatin Technologies to Develop PL8177 as a Potential Treatment for COVID-19 and Associated Lung Complications PR Newswire
Jun-05-20 03:14PM	Do Hedge Funds Love Palatin Technologies, Inc. (PTN)? Insider Monkey
May-14-20 07:02PM	Palatin Stock Could Soar by Over 300% in the Next Year, Says Top Analyst TipRanks
May-13-20 03:01AM	Palatin Technologies (PTN) Q3 2020 Earnings Call Transcript Motley Fool
May-12-20 07:30AM	Palatin Technologies, Inc. Reports Third Quarter Fiscal Year 2020 Financial Results and Recent Business Highlights PR Newswire
Apr-30-20 07:30AM	Palatin Technologies Provides Assessment of Impact of COVID-19 Pandemic on Business Operations PR Newswire
Mar-28-20 10:28AM	Does Palatin Technologies, Inc.'s (NYSEMKT:PTN) CEO Salary Compare Well With Others? Simply Wall St.
Mar-03-20 12:56PM	Analysts: These 3 Strong Buy Penny Stocks Could Gain Over 200% TipRanks
Feb-21-20 10:22AM	Introducing Palatin Technologies (NYSEMKT:PTN), A Stock That Climbed 69% In The Last Three Years Simply Wall St.
Feb-19-20 07:30AM	Palatin Technologies, Inc. Announces First Patient Enrolled in Dry Eye Disease Phase 2 Clinical Trial with PL9643 PR Newswire
Feb-11-20 07:30AM	Palatin Technologies, Inc. Reports Second Quarter Fiscal Year 2020 Financial Results and Recent Business Highlights PR Newswire -14.68%
Feb-06-20 07:30AM	Palatin Technologies, Inc. to Report Second Quarter Fiscal Year 2020 Results; Teleconference and Webcast to be held on February 11, 2020 PR Newswire
Jan-21-20 07:30AM	Palatin Provides Corporate Update and 2020 Calendar Outlook PR Newswire
Jan-16-20 08:36AM	Should We Be Delighted With Palatin Technologies, Inc.'s (NYSEMKT:PTN) ROE Of 38%? Simply Wall St.
Dec-20-19 05:13PM	Is Palatin Technologies, Inc. (PTN) Going To Burn These Hedge Funds ? Insider Monkey
Dec-11-19 11:43AM	Is Palatin Technologies, Inc. (NYSEMKT:PTN) A Volatile Stock? Simply Wall St.
Dec-03-19 11:44PM	Edited Transcript of PTN earnings conference call or presentation 13-Nov-19 4:00pm GMT Thomson Reuters StreetEvents
Nov-13-19 07:30AM	Palatin Technologies, Inc. Reports First Quarter Fiscal Year 2020 Results and Provides Corporate Update PR Newswire
Nov-07-19 07:30AM	Palatin Technologies, Inc. to Report First Quarter Fiscal Year 2020 Results; Teleconference and Webcast to be held on November 13, 2019 PR Newswire
Oct-31-19 11:53AM	Does Palatin Technologies (NYSEMKT:PTN) Deserve A Spot On Your Watchlist? Simply Wall St.
Oct-17-19 07:00AM	Palatin Presents On Pl8177 Oral Colon Delivery Formulation For Ulcerative Colitis At The 7Th CPC Symposium On Peptide Therapeutics PR Newswire
Oct-16-19 07:00AM	Vyleesi Phase 3 Data To Be Presented At The 13th European Society Of Gynecology Congress PR Newswire
Oct-08-19 02:06PM	How Many Palatin Technologies, Inc. (NYSEMKT:PTN) Shares Do Institutions Own? Simply Wall St.
Sep-17-19 05:41PM	Edited Transcript of PTN earnings conference call or presentation 12-Sep-19 3:00pm GMT Thomson Reuters StreetEvents
08:42AM	Should You Consider Palatin Technologies, Inc. (NYSEMKT:PTN)? Simply Wall St.
Sep-12-19 07:30AM	Palatin Technologies, Inc. Reports Fourth Quarter and Fiscal Year 2019 Results PR Newswire
Sep-11-19 12:00PM	Palatin Technologies, Inc. to Report Fourth Quarter & Fiscal Year End 2019 Results; Teleconference and Webcast to be held on September 12, 2019 PR Newswire
Aug-19-19 10:44AM	Can You Imagine How Palatin Technologies's (NYSEMKT:PTN) Shareholders Feel About The 80% Share Price Increase? Simply Wall St.
Aug-16-19 10:42AM	Palatin's (PTN) to Report Q4 Earnings: What's in the Cards? Zacks +6.07%
Aug-13-19 05:45PM	Palatin (PTN) Stock Sinks As Market Gains: What You Should Know Zacks
Aug-06-19 09:30AM	Is Palatin Technologies (PTN) Outperforming Other Medical Stocks This Year? Zacks +20.18%
07:00AM	Palatin Technologies To Present At Canaccord Genuity's 39th Annual Growth Conference PR Newswire
Jul-26-19 05:45PM	Palatin (PTN) Stock Sinks As Market Gains: What You Should Know Zacks
Jul-19-19 05:45PM	Palatin (PTN) Gains As Market Dips: What You Should Know Zacks
Jul-17-19 09:30AM	Is Palatin Technologies (PTN) Outperforming Other Medical Stocks This Year? Zacks
Jul-12-19 12:51PM	Should You Worry About Palatin Technologies, Inc.'s (NYSEMKT:PTN) CEO Pay Cheque? Simply Wall St.
Jul-01-19 07:00AM	Palatin Technologies Provides Mid-Calendar Year Corporate Update PR Newswire -6.03%
Jun-25-19 03:49PM	Why Palatin Technologies Stock Dropped as Much as 21.5% Today Motley Fool -9.09%
Jun-24-19 04:45PM	Dow ekes out gain but fresh Iran sanctions drag broader stock market lower MarketWatch -9.70%
04:19PM	Palatin Jumps Then Pulls Back After FDA Clears Sexual-Desire Drug for Women TheStreet.com
10:54AM	Companies to Watch: Spotify downgraded, FDA signs off on Palatin drug, FedEx cuts prices Yahoo Finance
08:03AM	Palatin's stock rockets after FDA OK to market sexual desire disorder treatment MarketWatch
Jun-21-19 05:41PM	AMAG stock rallies on FDA approval for drug to increase women's sex drive MarketWatch
05:40PM	FDA Approves New Drug Application for Vyleesi (bremelanotide injection) PR Newswire
05:13PM	FDA approves drug for loss of female sexual desire Reuters
Jun-06-19 07:30AM	Palatin Technologies Granted FDA Orphan Drug Designation -- PL-8177 for the Treatment of Non-Infectious Uveitis PR Newswire -6.62%
May-20-19 03:48PM	Edited Transcript of PTN earnings conference call or presentation 9-May-19 3:00pm GMT Thomson Reuters StreetEvents +8.39%
May-14-19 08:17AM	What Does Poltronic S.A.'s (WSE:PTN) Balance Sheet Tell Us About It? Simply Wall St.
May-10-19 01:23PM	Palatin Technologies (PTN) Q3 2019 Earnings Call Transcript Motley Fool
May-09-19 09:00AM	Palatin Technologies, Inc. to Host Earnings Call ACCESSWIRE
07:30AM	Palatin Technologies, Inc. Reports Third Quarter Fiscal Year 2019 Results; Teleconference and Webcast to be held on May 9, 2019 PR Newswire
May-03-19 04:30PM	Palatin Technologies, Inc. to Report Third Quarter Fiscal Year 2019 Results; Teleconference and Webcast to be held on May 9, 2019 PR Newswire
Apr-15-19 09:27AM	What Kind Of Share Price Volatility Should You Expect For Palatin Technologies, Inc. (NYSEMKT:PTN)? Simply Wall St.
Apr-05-19 10:46AM	Palatin Technologies (PTN) in Focus: Stock Moves 5.7% Higher Zacks
Apr-04-19 07:30AM	Palatin Technologies Announces Positive Top Line Results of Oral Clinical Study of PL-8177 for Ulcerative Colitis and Other Inflammatory Bowel Diseases PR Newswire +5.74%
Mar-02-19 08:34AM	The Palatin Technologies Share Price Has Gained 103%, So Why Not Pay It Some Attention? Simply Wall St.
Feb-26-19 07:40AM	Analysis: Positioning to Benefit within Weatherford International, NiSource, Palatin Technologies, Astronics, MaxLinear, and FutureFuel Research Highlights Growth, Revenue, and Consolidated Results GlobeNewswire
Feb-12-19 05:20PM	Edited Transcript of PTN earnings conference call or presentation 12-Feb-19 4:00pm GMT Thomson Reuters StreetEvents
07:30AM	Palatin Technologies, Inc. Reports Second Fiscal Quarter 2019 Results and Provides Corporate Update PR Newswire
Feb-06-19 07:30AM	Palatin Technologies, Inc. to Report Second Quarter Fiscal Year 2019 Results; Teleconference and Webcast to be held on February 12, 2019 PR Newswire
Dec-30-18 03:27PM	The Week Ahead In Biotech: Conferences, PDUFA Dates And Clinical Trials Benzinga
Dec-18-18 12:06PM	Palatin Technologies, Inc. (PTN): Hedge Fund Sentiment Unchanged Insider Monkey
Dec-07-18 02:20PM	Edited Transcript of PTN earnings conference call or presentation 13-Nov-18 4:00pm GMT Thomson Reuters StreetEvents
Nov-27-18 07:40AM	Market Trends Toward New Normal in Palatin Technologies, Revance Therapeutics, Geo Group, QUANTENNA COMMS, The Navigators Group, and INVESCO MORTGAGE CAPITAL INC Emerging Consolidated Expectations, Analyst Ratings GlobeNewswire
Nov-17-18 08:08AM	Heres What Palatin Technologies Incs (NYSEMKT:PTN) P/E Ratio Is Telling Us Simply Wall St.
Nov-13-18 08:11AM	What Kind Of Shareholders Own Palatin Technologies Inc (NYSEMKT:PTN)? Simply Wall St. -12.24%
07:30AM	Palatin Technologies, Inc. Reports First Fiscal Quarter 2019 Results and Provides Corporate Update PR Newswire
Nov-11-18 08:51AM	Why Palatin Technologies Inc (NYSEMKT:PTN) Looks Like A Quality Company Simply Wall St.
Nov-08-18 07:30AM	Palatin Technologies, Inc. Announces First-in-Human Study Results of Subcutaneous Administration of PL-8177, An Investigational Melanocortin Receptor 1 Agonist PR Newswire
Nov-07-18 04:15PM	Palatin Technologies, Inc. to Report First Quarter Fiscal Year 2019 Results; Teleconference and Webcast to be held on November 13, 2018 PR Newswire
Nov-05-18 10:30AM	Earnings Preview: Palatin (PTN) Q1 Earnings Expected to Decline Zacks
Oct-12-18 07:55AM	Recent Analysis Shows Booz Allen Hamilton Holding, j2 Global, Leidos, The Hain Celestial Group, Palatin Technologies, and Marsh & McLennan Companies Market Influences Renewed Outlook, Key Drivers of Growth GlobeNewswire
Sep-18-18 10:33PM	Edited Transcript of PTN earnings conference call or presentation 13-Sep-18 3:00pm GMT Thomson Reuters StreetEvents
Sep-13-18 08:01AM	Should You Be Tempted To Buy Poltronic SA (WSE:PTN) Because Of Its PE Ratio? Simply Wall St.
07:30AM	Palatin Technologies, Inc. Reports Fourth Quarter and Fiscal Year 2018 Results PR Newswire
07:08AM	Palatin Technologies Inc (NYSEMKT:PTN): Risks You Need To Consider Before Buying Simply Wall St.
Sep-07-18 04:00PM	Palatin Technologies, Inc. to Report Fourth Quarter and Fiscal Year End 2018 Results; Teleconference and Webcast to be held on September 13, 2018 PR Newswire
Sep-02-18 09:41AM	The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials And Earnings Benzinga
Aug-10-18 07:30AM	Analysis: Positioning to Benefit within FIS, Helix Energy, Palatin Technologies, NiSource, Service Corporation International, and Summit Hotel Properties Research Highlights Growth, Revenue, and Consolidated Results GlobeNewswire
Jul-17-18 07:30AM	Free Pre-Market Technical Recap on TherapeuticsMD and Three Additional Healthcare Stocks ACCESSWIRE
Jun-25-18 04:56PM	Palatin Technologies Added to Russell 3000® Index PR Newswire -8.48%
08:05AM	Today's Research Reports on Stocks to Watch: 22nd Century Group and Palatin Technologies ACCESSWIRE

Palatin Technologies, Inc., a specialized biopharmaceutical company, develops targeted receptor-specific therapeutics for the treatment of various diseases in the United States. The company's lead product is Vyleesi, a melanocortin receptor agonist for the treatment of premenopausal women with acquired, generalized hypoactive sexual desire disorder. It is also developing oral PL8177, a selective melanocortin receptor (MCr) 1 agonist peptide that has completed Phase I clinical trial for the treatment of inflammatory bowel diseases; and systemic PL8177, which has completed Phase I clinical trial for treating non-infectious uveitis and COVID-19. In addition, the company engages in the development of PL9643, a peptide melanocortin agonist active at multiple MCrs, including MC1r and MC5r for anti-inflammatory ocular indications, such as dry eye disease; and melanocortin peptides for diabetic retinopathy. Further, it is developing PL3994, a natriuretic peptide receptor (NPR)-A agonist and synthetic mimetic of the endogenous neuropeptide hormone atrial natriuretic peptide for cardiovascular indications; and PL5028, a dual NPR-A and NPR-C agonist to treat cardiovascular and fibrotic diseases, including reducing cardiac hypertrophy and fibrosis. The company was founded in 1986 and is based in Cranbury, New Jersey.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
DEVEER ROBERT K JR	Director	Nov 18	Buy	0.41	54,000	22,140	728,638	Nov 30 09:35 PM
DEVEER ROBERT K JR	Director	Sep 29	Sale	0.46	54,000	24,980	643,472	Oct 02 04:15 PM

open in yahoo | open in reuters | open in google

Upgrade your FINVIZ experience